Devolution determines how a UK marketing authorisation translates into publicly funded patient access. England, Scotland, Wales and Northern Ireland each control health policy and service organisation within devolved responsibilities, while the UK Government leads English policy and retains UK-wide functions including human medicines regulation. Each nation therefore has its own health institutions and budget within a shared regulatory state.
All four systems follow the predominantly tax-funded National Health Service model. Entitlement rests broadly on residence and eligibility, with most care provided according to clinical need rather than ability to pay. Defined patient charges and separate rules for some visitors and migrants remain.
The country access framework therefore combines UK-wide licensing with nation-specific assessment, funding and implementation. England and Wales rely extensively on National Institute for Health and Care Excellence guidance, Scotland uses the Scottish Medicines Consortium, and Northern Ireland endorses and implements relevant NICE guidance through its own institutions. These territorial differences recur throughout the UK access system.
If you would like to consult our Briefings please login at the top of the page or consult subscription options by clicking on the button below:
In this section subscribers can consult descriptions of the following stages of the national access process, with links to key sources of additional information:
- Healthcare system
- Access landscape
- Horizon scanning in England
- Horizon scanning in Scotland and Wales
- Scientific advice
- Regulatory approval
- Health technology assessment - England
- Health technology assessment - Scotland
- Health technology assessment - Wales
- Health technology assessment - Northern Ireland
- Price setting and rebate system
- Early access opportunities
- Additional funding opportunities
- Innovative medicines